Antibiotics, Acid-Suppressive Meds Tied to Allergic Disease

Share this content:
Antibiotics, Acid-Suppressive Meds Tied to Allergic Disease
Antibiotics, Acid-Suppressive Meds Tied to Allergic Disease

MONDAY, April 2, 2018 (HealthDay News) -- The use of acid-suppressive medications and antibiotics during the first six months of infancy is tied to subsequent development of allergic disease, according to a study published online April 2 in JAMA Pediatrics.

Edward Mitre, M.D., from the Uniformed Services University of the Health Sciences in Bethesda, Md., and colleagues assessed whether there is an association between the use of acid-suppressive medications or antibiotics in the first six months of infancy and development of allergic diseases in early childhood. The authors utilized data from 792,130 children who were Department of Defense TRICARE beneficiaries (born between Oct. 1, 2001, and Sept. 30, 2013).

The researchers found that 7.6 percent of included children were prescribed a histamine-2 receptor antagonist (H2RA), 1.7 percent a proton pump inhibitor (PPI), and 16.6 percent an antibiotic during the first six months of life. Over a median 4.6 years of follow-up, for children prescribed H2RAs and PPIs the adjusted hazard ratios for food allergy were 2.18 and 2.59, respectively. Corresponding hazard ratios were 1.70 and 1.84 for medication allergy, 1.51 and 1.45 for anaphylaxis, 1.50 and 1.44 for allergic rhinitis, and 1.25 and 1.41 for asthma. Following antibiotic prescription the adjusted hazard ratios were 2.09 for asthma, 1.75 for allergic rhinitis, 1.51 for anaphylaxis, and 1.42 for allergic conjunctivitis.

"Acid-suppressive medications and antibiotics should be used during infancy only in situations of clear clinical benefit," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »